Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The worldwide Geriatric Medicine market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 4.9% during the forecast period.
This report presents the market size and development trends by detailing the Geriatric Medicine market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Geriatric Medicine market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Geriatric Medicine industry and will help you to build a panoramic view of the industrial development.
Geriatric Medicine Market, By Type:
Anticoagulant
Proton-pump inhibitors (PPIs)
Antidiabetic
Statins
Antihypertensive
Analgesic
Antipsychotic
Others
Geriatric Medicine Market, By Application:
Respiratory
Osteoporosis
Neurological
Cancer
Arthritis
Cardiovascular
Others
Some of the leading players are as follows:
Eli Lilly and Company
GlaxoSmithKline plc
AstraZeneca plc
Sanofi S.A.
Abbott Laboratories, Inc
Sanofi SA.
Novartis International AG.
Pfizer, Inc
Boehringer Ingelheim GmbH.
Bristol-Myers Squibb Company
Geographically, Major regions are analyzed in details are as follows:
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East & Africa
Table of Contents
1 Methodology and Scope
-
1.1 Market Segmentation & Scope
-
1.1.1 Technology Type
-
1.1.2 Product
-
1.1.3 Application
-
1.1.4 Regional scope
-
1.1.5 Estimates and forecast timeline
-
1.2 Research Methodology
-
1.3 Information Procurement
-
1.3.1 Purchased database
-
1.3.2 Internal database
-
1.3.3 Secondary sources
-
1.3.4 Primary research
-
1.3.5 Details of primary research
-
1.4 Information or Data Analysis
-
1.4.1 Data analysis models
-
1.5 Market Formulation & Validation
-
1.6 Model Details
-
1.6.1 Commodity flow analysis
-
1.6.2 Volume price analysis
-
1.7 List of Secondary Sources
-
1.8 List of Abbreviations
2 Executive Summary
-
2.1 Market Outlook
-
2.2 Segment Outlook
3 Market Variables, Trends, & Scope
-
3.1 Market Lineage Outlook
-
3.1.1 Parent market outlook
-
3.1.2 Ancillary market outlook
-
3.2 Market Segmentation
-
3.2.1 Analysis
-
3.3 Market Dynamics
-
3.3.1 Market driver analysis
-
3.3.2 Market restraint analysis
-
3.3.3 Industry opportunities
-
3.4 Penetration & Growth Prospect Mapping
-
3.4.1 Penetration & growth prospect mapping analysis
-
3.5 Business Environment Analysis Tools
-
3.5.1 Porter's five forces analysis
-
3.5.2 PESTLE analysis
-
3.5.3 Major deals & strategic alliances analysis
4 Geriatric Medicine Market: Technology Type Analysis
-
4.1 Geriatric Medicine Technology Type Market Share Analysis, 2018 & 2026
-
4.2 Geriatric Medicine Technology Type Market: Segment Dashboard
-
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment
4.3.1 Anticoagulant
4.3.2 Proton-pump inhibitors (PPIs)
4.3.3 Antidiabetic
4.3.4 Statins
4.3.5 Antihypertensive
4.3.6 Analgesic
4.3.7 Antipsychotic
4.3.8 Others
5 Geriatric Medicine Market: Product Analysis
-
5.1 Geriatric Medicine Product Market Share Analysis, 2018 & 2026
-
5.2 Geriatric Medicine Product Market: Segment Dashboard
-
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment
6 Geriatric Medicine Market: Application Analysis
-
6.1 Geriatric Medicine Application Market Share Analysis, 2018 & 2026
-
6.2 Geriatric Medicine Application Market: Segment Dashboard
-
6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment
6.3.1 Respiratory
6.3.2 Osteoporosis
6.3.3 Neurological
6.3.4 Cancer
6.3.5 Arthritis
6.3.6 Cardiovascular
6.3.7 Others
7 Geriatric Medicine Market: Regional Analysis
-
7.1 Geriatric Medicine Regional Market Share Analysis, 2018 & 2026
-
7.2 Geriatric Medicine Regional Market: Segment Dashboard
-
7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)
-
7.4 List of Players at Regional Level
-
7.4.1 North America
-
7.4.2 Europe
-
7.4.3 Asia Pacific
-
7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
-
7.5.1 North America
-
7.5.2 Europe
-
7.5.3 Asia Pacific
-
7.5.4 Latin America
-
7.5.5 MEA
-
7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026
-
7.6.1 North America
-
7.6.2 Europe
-
7.6.3 Asia Pacific
-
7.6.4 Latin America
-
7.6.5 Middle East & Africa
8 Competitive Analysis
-
8.1 Recent Developments & Impact Analysis, by Key Market Participants
-
8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)
-
8.3 Vendor Landscape
-
8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)
9 Company Profiles
9.1 Eli Lilly and Company
9.1.1 Eli Lilly and Company Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.1.5 SWOT analysis
9.2 GlaxoSmithKline plc
9.2.1 GlaxoSmithKline plc Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.2.5 SWOT analysis
9.3 AstraZeneca plc
9.3.1 AstraZeneca plc Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.3.5 SWOT analysis
9.4 Sanofi S.A.
9.4.1 Sanofi S.A. Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.4.5 SWOT analysis
9.5 Abbott Laboratories, Inc
9.5.1 Abbott Laboratories, Inc Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.5.5 SWOT analysis
9.6 Sanofi SA.
9.6.1 Sanofi SA. Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.6.5 SWOT analysis
9.7 Novartis International AG.
9.7.1 Novartis International AG. Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.7.5 SWOT analysis
9.8 Pfizer, Inc
9.8.1 Pfizer, Inc Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.8.5 SWOT analysis
9.9 Boehringer Ingelheim GmbH.
9.9.1 Boehringer Ingelheim GmbH. Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.9.5 SWOT analysis
9.10 Bristol-Myers Squibb Company
9.10.1 Bristol-Myers Squibb Company Company overview
9.10.2 Financial performance
9.10.3 Product benchmarking
9.10.4 Strategic initiatives
9.10.5 SWOT analysis
The List of Tables and Figures (Totals 75 Figures and 145 Tables)
Figure Anticoagulant Geriatric Medicine market, 2015 - 2026 (USD Million)
Figure Proton-pump inhibitors (PPIs) Geriatric Medicine market, 2015 - 2026 (USD Million)
Figure Antidiabetic Geriatric Medicine market, 2015 - 2026 (USD Million)
Figure Statins Geriatric Medicine market, 2015 - 2026 (USD Million)
Figure Antihypertensive Geriatric Medicine market, 2015 - 2026 (USD Million)
Figure Analgesic Geriatric Medicine market, 2015 - 2026 (USD Million)
Figure Antipsychotic Geriatric Medicine market, 2015 - 2026 (USD Million)
Figure Others Geriatric Medicine market, 2015 - 2026 (USD Million)
Figure Respiratory market, 2015 - 2026 (USD Million)
Figure Osteoporosis market, 2015 - 2026 (USD Million)
Figure Neurological market, 2015 - 2026 (USD Million)
Figure Cancer market, 2015 - 2026 (USD Million)
Figure Arthritis market, 2015 - 2026 (USD Million)
Figure Cardiovascular market, 2015 - 2026 (USD Million)
Figure Others market, 2015 - 2026 (USD Million)
-
Table List of players in North America
-
Table List of players in Europe
-
Table List of players in Asia Pacific
-
Table SWOT analysis
-
Table North America Geriatric Medicine market, by country, 2015 - 2026 (USD Million)
-
Table North America Geriatric Medicine market, by type, 2015 - 2026 (USD Million)
-
Table North America Geriatric Medicine market, by product, 2015 - 2026 (USD Million)
-
Table North America Geriatric Medicine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.S. Geriatric Medicine market, by type, 2015 - 2026 (USD Million)
-
Table U.S. Geriatric Medicine market, by product, 2015 - 2026 (USD Million)
-
Table U.S. Geriatric Medicine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Canada Geriatric Medicine market, by type, 2015 - 2026 (USD Million)
-
Table Canada Geriatric Medicine market, by product, 2015 - 2026 (USD Million)
-
Table Canada Geriatric Medicine market, by application, 2015 - 2026 (USD Million)
-
Table Europe Geriatric Medicine market, by country, 2015 - 2026 (USD Million)
-
Table Europe Geriatric Medicine market, by type, 2015 - 2026 (USD Million)
-
Table Europe Geriatric Medicine market, by product, 2015 - 2026 (USD Million)
-
Table Europe Geriatric Medicine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.K. Geriatric Medicine market, by type, 2015 - 2026 (USD Million)
-
Table U.K. Geriatric Medicine market, by product, 2015 - 2026 (USD Million)
-
Table U.K. Geriatric Medicine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Germany Geriatric Medicine market, by type, 2015 - 2026 (USD Million)
-
Table Germany Geriatric Medicine market, by product, 2015 - 2026 (USD Million)
-
Table Germany Geriatric Medicine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table France Geriatric Medicine market, by type, 2015 - 2026 (USD Million)
-
Table France Geriatric Medicine market, by product, 2015 - 2026 (USD Million)
-
Table France Geriatric Medicine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Italy Geriatric Medicine market, by type, 2015 - 2026 (USD Million)
-
Table Italy Geriatric Medicine market, by product, 2015 - 2026 (USD Million)
-
Table Italy Geriatric Medicine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Spain Geriatric Medicine market, by type, 2015 - 2026 (USD Million)
-
Table Spain Geriatric Medicine market, by product, 2015 - 2026 (USD Million)
-
Table Spain Geriatric Medicine market, by application, 2015 - 2026 (USD Million)
-
Table Asia Pacific Geriatric Medicine market, by country, 2015 - 2026 (USD Million)
-
Table Asia Pacific Geriatric Medicine market, by type, 2015 - 2026 (USD Million)
-
Table Asia Pacific Geriatric Medicine market, by product, 2015 - 2026 (USD Million)
-
Table Asia Pacific Geriatric Medicine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table China Geriatric Medicine market, by type, 2015 - 2026 (USD Million)
-
Table China Geriatric Medicine market, by product, 2015 - 2026 (USD Million)
-
Table China Geriatric Medicine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Japan Geriatric Medicine market, by type, 2015 - 2026 (USD Million)
-
Table Japan Geriatric Medicine market, by product, 2015 - 2026 (USD Million)
-
Table Japan Geriatric Medicine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table India Geriatric Medicine market, by type, 2015 - 2026 (USD Million)
-
Table India Geriatric Medicine market, by product, 2015 - 2026 (USD Million)
-
Table India Geriatric Medicine market, by application, 2015 - 2026 (USD Million)
-
Table Latin America Geriatric Medicine market, by country, 2015 - 2026 (USD Million)
-
Table Latin America Geriatric Medicine market, by type, 2015 - 2026 (USD Million)
-
Table Latin America Geriatric Medicine market, by product, 2015 - 2026 (USD Million)
-
Table Latin America Geriatric Medicine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Brazil Geriatric Medicine market, by type, 2015 - 2026 (USD Million)
-
Table Brazil Geriatric Medicine market, by product, 2015 - 2026 (USD Million)
-
Table Brazil Geriatric Medicine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Mexico Geriatric Medicine market, by type, 2015 - 2026 (USD Million)
-
Table Mexico Geriatric Medicine market, by product, 2015 - 2026 (USD Million)
-
Table Mexico Geriatric Medicine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Argentina Geriatric Medicine market, by type, 2015 - 2026 (USD Million)
-
Table Argentina Geriatric Medicine market, by product, 2015 - 2026 (USD Million)
-
Table Argentina Geriatric Medicine market, by application, 2015 - 2026 (USD Million)
-
Table MEA Geriatric Medicine market, by country, 2015 - 2026 (USD Million)
-
Table MEA Geriatric Medicine market, by type, 2015 - 2026 (USD Million)
-
Table MEA Geriatric Medicine market, by product, 2015 - 2026 (USD Million)
-
Table MEA Geriatric Medicine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table South Africa Geriatric Medicine market, by type, 2015 - 2026 (USD Million)
-
Table South Africa Geriatric Medicine market, by product, 2015 - 2026 (USD Million)
-
Table South Africa Geriatric Medicine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Nigeria Geriatric Medicine market, by type, 2015 - 2026 (USD Million)
-
Table Nigeria Geriatric Medicine market, by product, 2015 - 2026 (USD Million)
-
Table Nigeria Geriatric Medicine market, by application, 2015 - 2026 (USD Million)
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Company market position analysis
Table Company Profiles
Table Eli Lilly and Company Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table GlaxoSmithKline plc Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table AstraZeneca plc Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Sanofi S.A. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Abbott Laboratories, Inc Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Sanofi SA. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Novartis International AG. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Pfizer, Inc Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Boehringer Ingelheim GmbH. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Bristol-Myers Squibb Company Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
-
